Corvus Pharmaceuticals (CRVS) Treasury Shares (2015 - 2024)

Corvus Pharmaceuticals (CRVS) recorded quarterly Treasury Shares of $400000.0 in Q3 2024, little changed quarter-over-quarter from $400000.0 in Q2 2024.

Corvus Pharmaceuticals (CRVS) Treasury Shares (2015 - 2024) Analysis & Trends

Corvus Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $400000.0 for Q3 2024.

  • In Q3 2024, Treasury Shares changed N/A year-over-year to $400000.0; the TTM figure through Sep 2024 stood at $400000.0 (changed N/A YoY), while the FY2023 annual figure was $400000.0, changed N/A from the prior year.
  • Treasury Shares was $400000.0 for Q3 2024 at Corvus Pharmaceuticals, roughly flat from $400000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $400000.0 in Q4 2023 to a low of $400000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 1.48 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 700,000.00
9 Abivax 91.71 Bn 91.71 Bn - -
10 Corvus Pharmaceuticals 1.00 Bn 766.75 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 400,000.00
Sep 30, 2024 400,000.00
Jun 30, 2024 400,000.00
Jun 30, 2024 400,000.00
Dec 31, 2023 400,000.00
Dec 31, 2023 400,000.00
Jun 30, 2019 12,384.00
Jun 30, 2019 12,384.00
Mar 31, 2019 27,073.00
Mar 31, 2019 27,073.00
Dec 31, 2018 43,076.00
Dec 31, 2018 43,076.00
Sep 30, 2018 99,831.00
Sep 30, 2018 99,831.00
Jun 30, 2018 172,955.00
Jun 30, 2018 172,955.00
Mar 31, 2018 246,079.00
Mar 31, 2018 246,079.00
Dec 31, 2017 319,203.00
Dec 31, 2017 319,203.00